Nuvalent Newsroom

Piper Sandler Maintains Nuvalent(NUVL.US) With Buy Rating, Raises Target Price to $100

Moomoo NewsAug 30 07:33 ET

Nuvalent Initiated at Overweight by Barclays

Dow JonesAug 29 08:59 ET

Nuvalent Analyst Ratings

BenzingaAug 29 08:51 ET

Barclays Initiates Nuvalent(NUVL.US) With Buy Rating, Announces Target Price $100

Moomoo NewsAug 29 04:32 ET

Nuvalent (NUVL) Receives a Buy From Barclays

TipRanksAug 29 04:08 ET

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Nuvalent (NUVL) and Dianthus Therapeutics (DNTH)

TipRanksAug 13 09:44 ET

Buy Rating Affirmed for Nuvalent Amid Promising NVL-655 Clinical Trial Progress and Anticipated Efficacy Superiority

TipRanksAug 8 17:32 ET

Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Next Science Ltd (OtherNXSCF)

TipRanksAug 7 05:09 ET

Jefferies Maintains Nuvalent(NUVL.US) With Buy Rating, Maintains Target Price $97

Moomoo NewsAug 1 10:32 ET

Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Alphatec Holdings (ATEC)

TipRanksAug 1 09:44 ET

Nuvalent's Promising Clinical Data and Differentiation in NSCLC Trials Bolster Buy Rating

TipRanksAug 1 09:42 ET

Nuvalent Analyst Ratings

BenzingaJul 10 09:24 ET

Nuvalent Analyst Ratings

BenzingaMay 17 09:20 ET

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Bluebird Bio (BLUE) and Nuvalent (NUVL)

TipRanksMay 14 06:45 ET

Nuvalent (NUVL) Gets a Buy From Stifel Nicolaus

TipRanksMay 12 22:15 ET

Nuvalent's Promising Clinical Progress and Financial Stability Support Strong Buy Rating

TipRanksMay 10 08:30 ET

Nuvalent Analyst Ratings

BenzingaApr 17 07:57 ET

Nuvalent Analyst Ratings

BenzingaApr 1 10:58 ET

Nuvalent Analyst Ratings

BenzingaMar 6 11:01 ET

Nuvalent Analyst Ratings

BenzingaFeb 28 09:17 ET